CASTELLANI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 890
EU - Europa 721
AS - Asia 292
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
OC - Oceania 1
Totale 1909
Nazione #
US - Stati Uniti d'America 888
GB - Regno Unito 282
CN - Cina 278
SE - Svezia 115
IT - Italia 72
FR - Francia 65
IE - Irlanda 59
FI - Finlandia 38
DE - Germania 35
BE - Belgio 20
UA - Ucraina 14
VN - Vietnam 8
AT - Austria 7
EU - Europa 4
NL - Olanda 4
TR - Turchia 4
CA - Canada 2
LU - Lussemburgo 2
RU - Federazione Russa 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IN - India 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
SG - Singapore 1
SI - Slovenia 1
ZM - Zambia 1
Totale 1909
Città #
Southend 244
Chandler 238
Jacksonville 133
Woodbridge 113
Ann Arbor 98
Dublin 59
Beijing 50
Houston 42
Wilmington 34
Jinan 32
Verona 30
Nanjing 29
Lawrence 28
Princeton 28
Shenyang 27
Hebei 23
Brussels 20
Tianjin 15
Ashburn 14
Ningbo 13
Boardman 12
Haikou 12
Taizhou 12
Nanchang 10
Hangzhou 9
Dong Ket 8
Zhengzhou 8
Vienna 7
Auburn Hills 6
Falls Church 6
Fuzhou 6
Helsinki 6
Jiaxing 6
Norwalk 6
Redwood City 6
Guangzhou 5
Lanzhou 5
Taiyuan 5
Changsha 4
Düsseldorf 4
Milan 4
Villafranca di Verona 4
Cambridge 3
New York 3
Riva 3
Appiano Gentile 2
Augusta 2
Chicago 2
Clearwater 2
Dearborn 2
Groningen 2
Lancaster 2
Los Angeles 2
Luxembourg 2
Messina 2
San Francisco 2
San Mateo 2
Seattle 2
Amsterdam 1
Bari 1
Castelfranco Emilia 1
Changle 1
Cupertino 1
Empoli 1
Fairfield 1
Kharkov 1
Klyuchik 1
Leawood 1
Ljubljana 1
London 1
Montréal 1
Novokuznetsk 1
Prague 1
Redmond 1
Saint Louis 1
San Donato Milanese 1
Torino 1
Zagreb 1
Totale 1476
Nome #
Family based association analysis of TGFB1 as modifier gene in Cystic Fibrosis 110
Family based association analysis of TGFB1 as modifier gene in Cystic Fibrosis 110
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. 96
Association of IL4Ra gene with severity of lung disease in Cystic Fibrosis 95
Analisi del gene TGFb1 quale possibile modificatore del fenotipo in fibrosi cistica 92
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 91
IFRD1 gene polymorphisms are associated with nasal polyposis in cystic fibrosis patients 81
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 78
Evaluation of the disease liability of CFTR variants. 78
Hemodynamic predictors of long term survival in end stage cystic fibrosis 77
Why women do not ask for information on preconception health? A qualitative study. 77
Emerging issues in cystic fibrosis newborn screening. 76
Geni modificatori del fenotipo polmonare in Fibrosi Cistica 75
Family based association analysis of TGFB1 as modifier gene in Cystic Fibrosis 74
Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders-updated European recommandations 73
Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms 64
Cystic Fibrosis: Pre-conception and antenatal tests [Fibrosi cistica: Analisi preconcezionale e prenatale] 64
Cystic fibrosis carrier screening effects on birth prevalence and newborn screening 61
IL4Ra: un possibile gene modificatore del fenotipo polmonare in Fibrosi Cistica 55
Benchmarks for cystic fibrosis carrier screening: a European consensus document. 54
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 53
The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe 53
291 Colon cancer screening program in adult CF patients: an Italian cross-sectional pilot study 47
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 38
Cystic Fibrosis Diagnostic Challenges over 4 Decades: Historical Perspectives and Lessons Learned 36
Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses 33
Safety, tolerability and early signs of efficacy with riociguat for the treatment of adult Phe508del homozygous cystic fibrosis patients: study design and rationale for the Rio-CF study 33
Sweat chloride and immunoreactive trypsinogen in infants carrying two CFTR mutations and not affected by cystic fibrosis 33
Hemodynamic predictors of long term survival in end stage cystic fibrosis 24
Totale 1931
Categoria #
all - tutte 3860
article - articoli 2441
book - libri 0
conference - conferenze 1278
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 141
Totale 7720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20185 0000 00 00 0005
2018/2019174 114575 37 566 51406
2019/2020270 340619 1926 3621 13532221
2020/2021282 54462031 2327 418 633317
2021/2022278 2896634 99 414 961548
2022/2023582 477738110 51136 837 588120
Totale 1931